文献速递心脑血管急症重症综合管理与镇静镇痛

大核心梗死性卒中患者的血管内治疗与结局

Endovascular Therapy and Outcomes Among Patients With Very Large Ischemic Core Stroke.
PubMed 文献 · JAMA Netw Open · 2024-05-01
一句话结论NCCT示ASPECTS 0~2且发病24小时内的卒中患者,EVT组90天良好功能结局率高于SMT组(22.2% vs 9.9%),但sICH风险显著增高。

该研究基于中国38家卒中中心的前瞻性观察性全国登记队列,纳入2021年11月1日至2023年2月8日期间、发病24小时内、NCCT评估ASPECTS 0~2、颈内动脉或大脑中动脉M1/M2段闭塞的245例患者(EVT组135例,SMT组111例)。主要终点90天良好功能结局(mRS 0~3)EVT组30例(22.2%)vs SMT组11例(9.9%),aOR 3.07(95%CI 1.29-7.31),P=0.01。EVT组任何ICH和sICH风险均显著增高,90天死亡率两组无差异。作者认为需要随机临床试验评估这些发现。

要点

  • NCCT ASPECTS 0~2、发病24小时内、ICA或MCA M1/M2闭塞患者,EVT组90天mRS 0~3比例30/135(22.2%)vs SMT组11/111(9.9%),aOR 3.07(95%CI 1.29-7.31),P=0.01。
  • EVT组48小时内sICH 24/135(17.8%)vs SMT组1/111(0.9%),aOR 23.07(95%CI 2.99-177.79),P=0.003,出血风险显著增高。
  • EVT组48小时内任何ICH 56/135(41.5%)vs SMT组16/111(11.4%),aOR 4.27(95%CI 2.19-8.35),P<0.001。
  • 90天死亡率EVT组80/135(59.3%)vs SMT组59/111(53.2%),aOR 1.38(95%CI 0.77-2.47),P=0.28,两组无显著差异。

适用人群与场景

  • 发病24小时内、颈内动脉或大脑中动脉M1或M2段闭塞、非增强CT评估ASPECTS 0~2的卒中患者。
  • 数据来自中国38家卒中中心的前瞻性观察性全国登记,纳入2021年11月1日至2023年2月8日期间的患者。

诊断标准与关键阈值

  • ASPECTS 0~2分,基于非增强CT(NCCT)评分。
  • 主要终点良好功能结局定义为90天mRS 0~3。

研究设计与关键结果

  • 研究类型:前瞻性观察性全国登记队列研究,纳入38家卒中中心,共245例ASPECTS 0~2患者,EVT组135例(54.9%),SMT组111例(45.1%)。
  • 主要终点:90天良好功能结局(mRS 0~3)EVT组30例(22.2%)vs SMT组11例(9.9%),P=0.01,aOR 3.07(95%CI 1.29-7.31),P=0.01。
  • 安全性终点:48小时内任何ICH EVT组56例(41.5%)vs SMT组16例(11.4%),P<0.001,aOR 4.27(95%CI 2.19-8.35),P<0.001;sICH EVT组24例(17.8%)vs SMT组1例(0.9%),P<0.001,aOR 23.07(95%CI 2.99-177.79),P=0.003。
  • 90天死亡率EVT组80例(59.3%)vs SMT组59例(53.2%),P=0.34,aOR 1.38(95%CI 0.77-2.47),P=0.28。
  • 倾向性评分匹配分析结果显示结果稳健。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究(全国登记)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对于发病24小时内基于NCCT评估ASPECTS 0~2的卒中患者,EVT与更高的良好功能结局几率相关,但sICH风险显著增高。
  • 作者指出需要随机临床试验评估这些发现。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The association of endovascular therapy (EVT) with outcomes is unclear for patients with very low Alberta Stroke Program Early Computed Tomography Score (ASPECTS) within 24 hours of stroke onset.

OBJECTIVE: To explore the association of EVT with functional and safety outcomes among patients with ASPECTS of 0 to 2 scored with noncontrast computed tomography.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from an ongoing, prospective, observational, nationwide registry including all patients treated at 38 stroke centers in China with an occlusion in the internal carotid artery or M1 or M2 segment of the middle cerebral artery within 24 hours of witnessed symptom onset. Patients with ASPECTS of 0 to 2 between November 1, 2021, and February 8, 2023, were included in analysis. Data were analyzed October to November 2023.

EXPOSURES: EVT vs standard medical treatment (SMT).

MAIN OUTCOMES AND MEASURES: The primary outcome was favorable functional outcome, defined as modified Rankin Scale score (mRS) of 0 to 3, at 90 days. Safety outcomes included symptomatic intracerebral hemorrhage (sICH) within 48 hours and mortality at 90 days.

RESULTS: A total of 245 patients (median [IQR] age, 71 [63-78] years; 118 [48%] women) with ASPECTS of 0 to 2 were included, of whom 111 patients (45.1%) received SMT and 135 patients (54.9%) received EVT. The EVT group had significantly greater odds of favorable functional outcome at 90 days than the SMT group (30 patients [22.2%] vs 11 patients [9.9%]; P = .01; adjusted odds ratio [aOR], 3.07 [95% CI, 1.29-7.31]; P = .01). Patients in the EVT group, compared with the SMT group, had significantly greater odds of any ICH (56 patients [41.5%] vs 16 patients [11.4%]; P < .001; aOR, 4.27 [95% CI, 2.19-8.35]; P < .001) and sICH (24 patients [17.8%] vs 1 patient [0.9%]; P < .001; aOR, 23.07 [95% CI, 2.99-177.79]; P = .003) within 48 hours. There were no differences between groups for 90-day mortality (80 patients [59.3%] vs 59 patients [53.2%]; P = .34; aOR, 1.38 [95% CI, 0.77-2.47]; P = .28). The results remained robust in the propensity score-matched analysis.

CONCLUSIONS AND RELEVANCE: In this cohort study of patients with very low ASPECTS based on NCCT within 24 hours of stroke onset, those treated with EVT had higher odds of a favorable functional outcome compared with those who received SMT. Randomized clinical trials are needed to assess these findings.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Xie D, Huang J, Fan S, et al. Endovascular Therapy and Outcomes Among Patients With Very Large Ischemic Core Stroke. JAMA Netw Open. 2024. PMID: 38696171. doi:10.1001/jamanetworkopen.2024.9298

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。